Nordson (NDSN) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
16 Jan, 2026Executive summary
Annual meeting scheduled for March 2, 2026, via live audio webcast for shareholders of record as of January 2, 2026.
Shareholders can access proxy materials online or request paper/email copies by February 20, 2026.
Voting matters and shareholder proposals
Election of three director nominees: Christopher Mapes, Michael Merriman, Jr., and Sundaram Nagarajan.
Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending October 31, 2026.
Advisory vote to approve compensation of named executive officers.
Provision for transaction of other business as may properly come before the meeting.
Board of directors and corporate governance
Board recommends voting FOR all three proposals on the agenda.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Nordson
- Record sales and earnings, with raised guidance and strong growth in ATS and Asia Pacific.NDSN
Q1 202619 Feb 2026 - Strong growth, innovation, and cash flow support 6-8% annual revenue growth through 2029.NDSN
Investor presentation19 Feb 2026 - Q3 sales up 2% to $662M; Atrion acquisition expands medical segment; guidance raised.NDSN
Q3 202423 Jan 2026 - 2025–2029 targets 6%-8% revenue and 10%-12% EPS growth, driven by strategy and portfolio evolution.NDSN
Investor Day 202420 Jan 2026 - Shareholders will vote on directors, auditor ratification, and executive pay amid record results and strong governance.NDSN
Proxy Filing16 Jan 2026 - Record sales and EBITDA in 2024; 2025 outlook targets growth, led by Atrion amid macro uncertainty.NDSN
Q4 202411 Jan 2026 - Sales fell 2.8% but backlog surged 15%, signaling growth potential for 2025.NDSN
Q1 20258 Jan 2026 - Record sales, strong margins, and robust cash flow set up for solid growth in 2026.NDSN
Q4 202512 Dec 2025 - Record financials, strong governance, and key votes headline the 2025 proxy.NDSN
Proxy Filing1 Dec 2025